InBody Co.,Ltd (KOSDAQ:041830)
South Korea · Delayed Price · Currency is KRW 31,600
-150 (-0.47%)
Oct 10, 2025, 3:30 PM KST
InBody Co.,Ltd Market Cap
InBody Co.,Ltd has a market cap or net worth of 385.28 billion as of October 10, 2025. Its market cap has increased by 24.79% in one year.
Market Cap
385.28B
Enterprise Value
300.47B
Revenue
217.55B
Ranking
n/a
PE Ratio
13.11
Stock Price
31,600.00
Market Cap Chart
Since November 3, 2004, InBody Co.,Ltd's market cap has increased from 10.60B to 385.28B, an increase of 3,533.99%. That is a compound annual growth rate of 18.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 385.28B | 29.50% |
| Dec 30, 2024 | 297.52B | -9.91% |
| Dec 28, 2023 | 330.23B | 25.50% |
| Dec 29, 2022 | 263.14B | -12.74% |
| Dec 30, 2021 | 301.57B | 33.43% |
| Dec 30, 2020 | 226.02B | -28.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |